Thyroid Ablation Devices Market Size, Share & Trends Analysis Report By Type (Radiofrequency, Microwave), By Product (Thermal, Non-thermal), By Application (Cancer, Nodules), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Thyroid Ablation Devices Market Growth & Trends
The global thyroid ablation devices market size is expected to reach USD 318.4 million by 2030, expanding at a CAGR of 9.58% from 2024 to 2030, according to a new report by Grand View Research, Inc. The availability of advanced treatment methods and the increasing prevalence of thyroid cancer is anticipated to augment the overall market growth. Commercialization and ongoing developments for technologically advanced thyroid ablation systems, and proven clinical efficacy are expected to favor the market demand. Ease of treatment as compared to other surgical procedures is anticipated to foster segment growth. The rising awareness about the benefits of thyroid ablation and an increasing number of thyroid cancer patients for surgical cancer treatment is predicted to foster the product demand.
Minimally invasive surgical procedures are gaining popularity over traditional surgeries due to various advantages, such as the need for smaller incisions, reduced pain, faster recovery time, and minimal scarring. In addition, in certain cases, minimally invasive surgery is considered more accurate than traditional surgery. Minimally invasive procedures reduce hospital stays, which helps in saving extra costs associated with the treatment. Thus, increasing preference for minimally invasive procedures is expected to contribute to market growth. Increasing cases of thyroid cancer across the globe is also likely to contribute to market growth. For instance, as per the American Cancer Society, around 43,720 new cases of thyroid cancer were observed in the U.S. This cancer is about 3 times more common in women than men, creating a high product demand among women.
Thyroid Ablation Devices Market Report Highlights
- The radiofrequency ablation segment held the largest market share in 2023 owing to the surge in its adoption rate due to its increased efficiency
- The devices segment held the largest revenue share in 2023 as these devices significantly decrease intraoperative blood loss and shorten the operational time
- The thyroid cancer segment is anticipated to gain the highest market share during the forecast period due to the rising number of thyroid-related cancer cases across the globe
- North America led the market in 2023 owing to the high product demand for the treatment of several thyroid diseases
- Asia Pacific is anticipated to exhibit the fastest growth rate during the forecast period owing to the increasing adoption of minimally invasive surgeries across several countries in Asia
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Product
- 1.1.3. Application
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Product outlook
- 2.2.3. Application outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Thyroid Ablation Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rising prevalence of thyroid cancer & thyroid nodules.
- 3.4.1.2. Growing preference for minimally invasive surgeries
- 3.4.1.3. Availability of technologically sound ablation procedures
- 3.4.2. Market restraint analysis
- 3.4.2.1. High cost of thyroid ablation devices
- 3.4.2.2. Lack of skilled professionals
- 3.5. Thyroid Ablation Devices Market Analysis Tools
- 3.5.1. Industry Analysis - Porter’s
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
- Chapter 4. Thyroid Ablation Devices Market: Type Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Radiofrequency Ablation
- 4.1.2. Microwave Ablation
- 4.1.3. Others
- 4.2. Type Market Share, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Thyroid Ablation Devices Market by Type Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Radiofrequency Ablation
- 4.5.1.1. Radiofrequency Ablation market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Microwave Ablation
- 4.5.2.1. Microwave Ablation market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Others
- 4.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Thyroid Ablation Devices Market: Product Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Thermal-based Devices
- 5.1.2. Non-thermal-based Devices
- 5.2. Product Market Share, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Thyroid Ablation Devices Market by Product Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Thermal-based Devices
- 5.5.1.1. Thermal-based devices market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Non-thermal-based Devices
- 5.5.2.1. Non-thermal-based devices market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Thyroid Ablation Devices Market: Application Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Thyroid Cancer
- 6.1.2. Thyroid Nodules
- 6.2. Application Market Share, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Thyroid Ablation Devices Market by Application Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Thyroid Cancer
- 6.5.1.1. Thyroid cancer market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Thyroid Nodules
- 6.5.2.1. Thyroid nodules market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. Thyroid Ablation Devices Market: End-use Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.1.1. Hospitals
- 7.1.2. Cancer Specialty Centers
- 7.1.3. Ambulatory Surgical Centers
- 7.1.4. Others
- 7.2. End-use Market Share, 2023 & 2030
- 7.3. Segment Dashboard
- 7.4. Thyroid Ablation Devices Market by End-use Outlook
- 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5.1. Hospitals
- 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 7.5.2. Cancer Specialty Centers
- 7.5.2.1. Cancer specialty centers market estimates and forecast 2018 to 2030 (USD Million)
- 7.5.3. Ambulatory Surgical Centers
- 7.5.3.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
- 7.5.4. Others
- 7.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 8. Thyroid Ablation Devices Market: Regional Estimates & Trend Analysis
- 8.1. Regional market share analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Regional Market Share and Leading Players, 2023
- 8.4.1. North America
- 8.4.2. Europe
- 8.4.3. Asia Pacific
- 8.4.4. Latin America
- 8.4.5. Middle East and Africa
- 8.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
- 8.6. North America
- 8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. U.S.
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 8.6.3. Canada
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory framework
- 8.6.3.4. Reimbursement scenario
- 8.6.3.5. Canada market estimates and forecasts, 2018 - 2030
- 8.7. Europe
- 8.7.1. UK
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Competitive Scenario
- 8.7.1.3. Regulatory framework
- 8.7.1.4. Reimbursement scenario
- 8.7.1.5. UK market estimates and forecasts, 2018 - 2030
- 8.7.2. Germany
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory framework
- 8.7.2.4. Reimbursement scenario
- 8.7.2.5. Germany market estimates and forecasts, 2018 - 2030
- 8.7.3. France
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory framework
- 8.7.3.4. Reimbursement scenario
- 8.7.3.5. France market estimates and forecasts, 2018 - 2030
- 8.7.4. Italy
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory framework
- 8.7.4.4. Reimbursement scenario
- 8.7.4.5. Italy market estimates and forecasts, 2018 - 2030
- 8.7.5. Spain
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory framework
- 8.7.5.4. Reimbursement scenario
- 8.7.5.5. Spain market estimates and forecasts, 2018 - 2030
- 8.7.6. Denmark
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Competitive Scenario
- 8.7.6.3. Regulatory framework
- 8.7.6.4. Reimbursement scenario
- 8.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 8.7.7. Sweden
- 8.7.7.1. Key country dynamics
- 8.7.7.2. Competitive Scenario
- 8.7.7.3. Regulatory framework
- 8.7.7.4. Reimbursement scenario
- 8.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 8.7.8. Norway
- 8.7.8.1. Key country dynamics
- 8.7.8.2. Competitive Scenario
- 8.7.8.3. Regulatory framework
- 8.7.8.4. Reimbursement scenario
- 8.7.8.5. Norway market estimates and forecasts, 2018 - 2030
- 8.8. Asia Pacific
- 8.8.1. Japan
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Competitive Scenario
- 8.8.1.3. Regulatory framework
- 8.8.1.4. Reimbursement scenario
- 8.8.1.5. Japan market estimates and forecasts, 2018 - 2030
- 8.8.2. India
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory framework
- 8.8.2.4. Reimbursement scenario
- 8.8.2.5. India market estimates and forecasts, 2018 - 2030
- 8.8.3. China
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory framework
- 8.8.3.4. Reimbursement scenario
- 8.8.3.5. China market estimates and forecasts, 2018 - 2030
- 8.8.4. South Korea
- 8.8.4.1. Key country dynamics
- 8.8.4.2. Competitive Scenario
- 8.8.4.3. Regulatory framework
- 8.8.4.4. Reimbursement scenario
- 8.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 8.8.5. Australia
- 8.8.5.1. Key country dynamics
- 8.8.5.2. Competitive Scenario
- 8.8.5.3. Regulatory framework
- 8.8.5.4. Reimbursement scenario
- 8.8.5.5. Australia market estimates and forecasts, 2018 - 2030
- 8.8.6. Thailand
- 8.8.6.1. Key country dynamics
- 8.8.6.2. Competitive Scenario
- 8.8.6.3. Regulatory framework
- 8.8.6.4. Reimbursement scenario
- 8.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 8.9. Latin America
- 8.9.1. Brazil
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Competitive Scenario
- 8.9.1.3. Regulatory framework
- 8.9.1.4. Reimbursement scenario
- 8.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 8.9.2. Mexico
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Competitive Scenario
- 8.9.2.3. Regulatory framework
- 8.9.2.4. Reimbursement scenario
- 8.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 8.9.3. Argentina
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Competitive Scenario
- 8.9.3.3. Regulatory framework
- 8.9.3.4. Reimbursement scenario
- 8.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 8.10. MEA
- 8.10.1. South Africa
- 8.10.1.1. Key country dynamics
- 8.10.1.2. Competitive Scenario
- 8.10.1.3. Regulatory framework
- 8.10.1.4. Reimbursement scenario
- 8.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 8.10.2. Saudi Arabia
- 8.10.2.1. Key country dynamics
- 8.10.2.2. Competitive Scenario
- 8.10.2.3. Regulatory framework
- 8.10.2.4. Reimbursement scenario
- 8.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 8.10.3. UAE
- 8.10.3.1. Key country dynamics
- 8.10.3.2. Competitive Scenario
- 8.10.3.3. Regulatory framework
- 8.10.3.4. Reimbursement scenario
- 8.10.3.5. UAE market estimates and forecasts, 2018 - 2030
- 8.10.4. Kuwait
- 8.10.4.1. Key country dynamics
- 8.10.4.2. Competitive Scenario
- 8.10.4.3. Regulatory framework
- 8.10.4.4. Reimbursement scenario
- 8.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Innovators
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2022
- 9.3.4. Boston Scientific Corporation
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Product benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. BVM Medical System
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Product benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. Integra Life Sciences
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Product benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Johnson & Johnson
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Product benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Medtronic Plc.
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Product benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. MedWaves Inc.,
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Product benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. Olympus Corporation
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Product benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. StarMed Co.Ltd
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Product benchmarking
- 9.3.11.4. Strategic initiatives
- 9.3.12. Terumo Europe
- 9.3.12.1. Company overview
- 9.3.12.2. Financial performance
- 9.3.12.3. Product benchmarking
- 9.3.12.4. Strategic initiatives
- 9.3.13. Theraclion
- 9.3.13.1. Company overview
- 9.3.13.2. Financial performance
- 9.3.13.3. Product benchmarking
- 9.3.13.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook